Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: Incidence, predictors, and outcomes

Circulation

Volumn 106, Issue 3, 2002, Pages 309-312

  Al Khatib, Sana M ^a   Granger, Christopher B ^a   Huang, Yao ^a   Lee, Kerry L ^a   Califf, Robert M ^a   Simoons, Maarten L ^b   Armstrong, Paul W ^c   Van De Werf, Frans ^d   White, Harvey D ^e   Simes, R John ^f   Moliterno, David J ^g   Topol, Eric J ^g   Harrington, Robert A ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e GREEN LANE HOSPITAL   (New Zealand)

^f UNIVERSITY OF SYDNEY   (Australia)

^g LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Coronary disease; Fibrillation; Mortality; Prognosis; Tachycardia

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; STREPTOKINASE;

ARTICLE; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; HYPERTENSION; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REDUCTION; ST SEGMENT; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SYNDROME; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 0037118702     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000022692.49934.E3     Document Type: Article

References (10)

1. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: Incidence and outcomes
2. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes
3. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
4. International, randomized, controlled trial of lamifiban (a glycoprotein IIb/IIIa Inhibitor), heparin, or both in unstable angina
5. Patient-specific dosing of IIb/IIIa antagonists during acute coronary syndromes: Rationale and design of the PARAGON B study
6. Regression models and life-tables
7. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: Results from an international trial of 9461 patients
8. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices
9. Randomised trial of intravenous atenolol among 16.027 cases of suspected acute myocardial infarction: ISIS-1
10. A randomized trial of propranolol in patients with acute myocardial infarction: I. Mortality results